Nurix Therapeutics, Inc. (NRIX)
Across 24 earnings reports since Oct 14, 2020, Nurix Therapeutics, Inc. (NRIX) has a clear post-earnings pattern. It moves ±5.80% on average after reporting and finishes higher 54.2% of the time. Its largest post-earnings gain was +20.63% (Apr 13, 2023) and its largest decline was -10.24% (Apr 10, 2024). The next earnings report is predicted for 2026-10-09 (approximate).
Earnings reactions
How NRIX moved on each past earnings report.
Earnings Impact
Total Earnings
24
Avg Abs. Movement
±5.80%
Positive %
54.2%
Negative %
45.8%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Jul 09, 2026 | ☽ POST | -6.56% | open_in_new |
| Apr 08, 2026 | ☀ PRE | -4.59% | open_in_new |
| Jan 28, 2026 | ☽ POST | -1.57% | open_in_new |
| Oct 09, 2025 | ☽ POST | -10.13% | open_in_new |
Earnings Count
24
Total earnings in dataset
Avg Abs. Movement
±5.80%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 10-Q | 20260709 | open_in_new SEC.gov |
| 8-K | 20260709 | open_in_new SEC.gov |
| 144 | 20260702 | open_in_new SEC.gov |
| 4 | 20260702 | open_in_new SEC.gov |
| 144 | 20260625 | open_in_new SEC.gov |
| 144 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 4 | 20260625 | open_in_new SEC.gov |
| 8-K | 20260611 | open_in_new SEC.gov |
| 8-K | 20260608 | open_in_new SEC.gov |
Frequently asked about NRIX earnings
When does Nurix Therapeutics, Inc. report earnings next? expand_more
Nurix Therapeutics, Inc. (NRIX)'s next earnings date is approximate for 2026-10-09. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does NRIX stock move after earnings? expand_more
Over 24 reports, NRIX has moved an average of ±5.80% the session after earnings, closing higher 54.2% of the time.
What was NRIX's biggest post-earnings move? expand_more
NRIX's largest post-earnings gain on record was +20.63% on Apr 13, 2023, and its largest decline was -10.24% on Apr 10, 2024.
Where can I find Nurix Therapeutics, Inc.'s SEC filings? expand_more
All of Nurix Therapeutics, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right